Sangfelt O - Search Results

1

DLEU2, frequently deleted in malignancy, functions as a critical host gene of the cell cycle inhibitory microRNAs miR-15a and miR-16-1.

Lerner M, Harada M, Lovén J, Castro J, Davis Z, Oscier D, Henriksson M, Sangfelt O, Grandér D, Corcoran MM. Lerner M, et al. Among authors: sangfelt o. Exp Cell Res. 2009 Oct 15;315(17):2941-52. doi: 10.1016/j.yexcr.2009.07.001. Epub 2009 Jul 8. Exp Cell Res. 2009. PMID: 19591824

2

Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoprotein.

Sangfelt O, Osterborg A, Grandér D, Anderbring E, Ost A, Mellstedt H, Einhorn S. Sangfelt O, et al. Int J Cancer. 1995 Oct 9;63(2):190-2. doi: 10.1002/ijc.2910630207. Int J Cancer. 1995. PMID: 7591202 Clinical Trial.

3

Primary leukemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA-binding factor interferon-stimulated gene factor 3.

Xu B, Grandér D, Sangfelt O, Einhorn S. Xu B, et al. Among authors: sangfelt o. Blood. 1994 Sep 15;84(6):1942-9. Blood. 1994. PMID: 8080997 Free article.

4

Wild-type p53-induced apoptosis in a Burkitt lymphoma cell line is inhibited by interferon gamma.

Sangfelt O, Einhorn S, Björklund AC, Wiman KG, Okan I, Grandér D. Sangfelt O, et al. Int J Cancer. 1996 Jul 3;67(1):106-12. doi: 10.1002/(SICI)1097-0215(19960703)67:1<106::AID-IJC18>3.0.CO;2-C. Int J Cancer. 1996. PMID: 8690509

5

Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-alpha in hematopoietic cell lines.

Sangfelt O, Erickson S, Einhorn S, Grandér D. Sangfelt O, et al. Oncogene. 1997 Jan 30;14(4):415-23. doi: 10.1038/sj.onc.1200832. Oncogene. 1997. PMID: 9053838

6

Induction of apoptosis and inhibition of cell growth are independent responses to interferon-alpha in hematopoietic cell lines.

Sangfelt O, Erickson S, Castro J, Heiden T, Einhorn S, Grandér D. Sangfelt O, et al. Cell Growth Differ. 1997 Mar;8(3):343-52. Cell Growth Differ. 1997. PMID: 9056677

7

How does interferon exert its cell growth inhibitory effect?

Grandér D, Sangfelt O, Erickson S. Grandér D, et al. Among authors: sangfelt o. Eur J Haematol. 1997 Sep;59(3):129-35. doi: 10.1111/j.1600-0609.1997.tb00965.x. Eur J Haematol. 1997. PMID: 9310119 Review.

8

Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence.

Erickson S, Sangfelt O, Heyman M, Castro J, Einhorn S, Grandér D. Erickson S, et al. Among authors: sangfelt o. Oncogene. 1998 Aug 6;17(5):595-602. doi: 10.1038/sj.onc.1201965. Oncogene. 1998. PMID: 9704925

9

In vivo induction of the interferon-stimulated protein 2'5'-oligoadenylate synthetase in tumor and peripheral blood cells during IFN-alpha treatment of metastatic melanoma.

Grandér D, Sangfelt O, Skoog L, Hansson J. Grandér D, et al. Among authors: sangfelt o. J Interferon Cytokine Res. 1998 Sep;18(9):691-5. doi: 10.1089/jir.1998.18.691. J Interferon Cytokine Res. 1998. PMID: 9781807

10

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D. Sangfelt O, et al. Oncogene. 1999 May 6;18(18):2798-810. doi: 10.1038/sj.onc.1202609. Oncogene. 1999. PMID: 10362250

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters